Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001246360-15-001885)

Filing Details

Accession Number:: 0001246360-15-001885
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-04-29 17:28:09
Reporting Period:: 2015-04-27

Filing Date:: 2015-04-29
Accepted Time:: 2015-04-29 17:28:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
911326	Synageva Biopharma Corp	GEVA	Biological Products, (No Disgnostic Substances) (2836)	561808663

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1532219	Anthony Quinn	33 Hayden Ave Lexington MA 02421	Evp, Cmo & Head Of R&D	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-04-27	10,000	$1.70	15,637	No	4	M	Direct
Common Stock	Disposition	2015-04-27	10,000	$110.00	5,637	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2015-04-27	10,000	$0.00	10,000	$1.70

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
37,228		2021-05-25	No	4	M	Direct

Footnotes

The sale of shares of the Company's common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 6, 2015.
The Stock Option granted the reporting person an option to purchase 47,228 shares of Common Stock (the "Shares"). 25% of the Shares vested and became exercisable on 05/25/2012, and 1/36 of the remainder of the Shares vest and become exercisable monthly thereafter.